Table 4 Treatment-related adverse events
Adverse events | Grade I-II | Grade III-IV | Grade V | Percentage |
|---|---|---|---|---|
Fatigue | 102 | 0 | 0 | 32.4 |
Nausea | 25 | 2 | 0 | 8.6 |
Diarrhoea | 37 | 1 | 0 | 12.1 |
Skin rash | 10 | 0 | 0 | 3.2 |
Glu Glutamic oxaloacetic transaminase/Alanine aminotransferase elevation | 15 | 3 | 2 | 5.7 |
Renal dysfunction | 8 | 0 | 0 | 2.5 |
Leucopenia | 93 | 80 | 0 | 54.9 |
Anaemia | 86 | 45 | 0 | 41.6 |
Thrombocytopenia | 31 | 18 | 0 | 15.6 |
Pneumonitis | 25 | 10 | 1 | 11.1 |
Myocarditis | 8 | 2 | 1 | 3.5 |
Endocrine toxicity | 3 | 0 | 0 | 1 |